Dark Forest Capital Management LP Denali Therapeutics Inc. Transaction History
Dark Forest Capital Management LP
- $634 Million
- Q4 2024
A detailed history of Dark Forest Capital Management LP transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Dark Forest Capital Management LP holds 12,888 shares of DNLI stock, worth $190,484. This represents 0.04% of its overall portfolio holdings.
Number of Shares
12,888Holding current value
$190,484% of portfolio
0.04%Shares
5 transactions
Others Institutions Holding DNLI
# of Institutions
237Shares Held
111MCall Options Held
80KPut Options Held
36.8K-
Black Rock Inc. New York, NY13.2MShares$195 Million0.01% of portfolio
-
Baillie Gifford & CO12.3MShares$182 Million0.2% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$178 Million0.0% of portfolio
-
Capital Research Global Investors Los Angeles, CA5.48MShares$81 Million0.02% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U05.36MShares$79.2 Million0.55% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $1.98B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...